Metraipolis › archive › dc_bd97b2e4d52d

The STAT3-ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancer — Europe PMC PMID:41800052

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41800052
DOI: 10.3389/fonc.2026.1699471
License (as archived): solo-consultazione
Archived: 2026-11-05T14:57:50.994Z
SHA-256 of the archived text: b3a9c6aab3369e8c3f813ae492249498d901fbcf327812af557a8bfb26676c7b
Stable URL of this page: https://metraipolis.com/documento/dc_bd97b2e4d52d

How to cite

The STAT3-ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancer — Europe PMC PMID:41800052 — Europe PMC (en), https://europepmc.org/article/MED/41800052 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd97b2e4d52d (Metraipolis archive dc_bd97b2e4d52d, sha256 b3a9c6aab3369e8c3f813ae492249498d901fbcf327812af557a8bfb26676c7b)

BibTeX

@misc{dcbd97b2e4d52d,
  title = {The STAT3-ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancer — Europe PMC PMID:41800052},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41800052},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd97b2e4d52d; sha256 b3a9c6aab3369e8c3f813ae492249498d901fbcf327812af557a8bfb26676c7b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41800052. Agents can read the archived copy with the MCP tool read_document.